To the Editor,
Multiple myeloma (MM) develops due to clonal expansion of malign plasma cells. Abnormal plasma cells secrete abnormal immunoglobulins that can be detected monoclonally (M peak) in serum and/or urine via electrophoresis. MM manifests clinically and radiologically with anemia, hypercalcemia, renal failure, and lytic lesions in bones [1] . When the characteristic MM clinical and radiological findings are observed, but there is no monoclonal M peak based on electrophoresis, it is known as non-secretory multiple myeloma (NSMM)-a rare variant of MM [2, 3] . NSMM is observed 1%-5% of all MM patients [4] . Hypercalcemia, which can present as mild to severe and life threatening, is the most common metabolic abnormality associated with MM, occurring in approximately 33% of patients [5] . Herein we report a patient diagnosed with NSMM after detecting hypercalcemia during follow-up 7 months after the start of hemodialysis treatment.
A 62-year-old male presented to our hospital with a 1-month history of left knee-joint pain. This patient began peritoneal dialysis following the diagnosis of chronic renal failure (CRF) 7 months earlier at another hospital, and then 1 month later began hemodialysis due to resistant peritonitis. Written informed consent was obtained from the patient. Physical examination findings were as follows: blood pressure: 100/60 mmHg; pulse: 90 bpm; temperature: 36.7 °C; respiration rate: 18 breaths min ; sedimentation: 40 mm h -1 ; parathormone: 6.6 pg mL -1 (normal range: 15-68 pg mL -1 ).
The patient was hemodialyzed with calcium dialysate 1.25 mmol L -1 and was hydrated. Steroid and zoledronic acid were initiated because the corrected calcium level increased to 17.12 mg dL -1 . On d 5 of treatment the calcium level returned to normal (9.3 mg dL -1). The patient's history of using drugs containing vitamin D and calcium was negative. Malignancy screening showed no pathological findings. Abdominal ultrasonography showed that kidney size was within the normal range. We performed protein electrophoresis due to the suspicion of MM in this patient with hypercalcemia, a positive CRF history, and normal kidney size. Monoclonal gammopathy was not observed in serum and urine protein electrophoresis, or immunofixation electrophoresis. Osteolytic bone lesions were observed via pelvic X-ray. Examination of specimens obtained via bone marrow aspiration and biopsy showed diffuse interstitial plasma cell infiltration (35% plasma cells). Immunohistochemical examination showed CD38 and kappa (κ) staining in infiltrative plasma cells, but no lambda (λ) staining. The patient was diagnosed as NSMM and referred to the hematology clinic.
In conclusion, in end-stage CRF patients with undefined hypercalcemia and bone pain, radiographically observed lytic bone lesions, and normal kidney size, but no M peak based on electrophoresis NSMM should be considered, and bone marrow aspiration and biopsy should be performed.
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